HAIN:NASDAQThe Hain Celestial Group, Inc. Analysis
Data as of 2026-04-07 - not real-time
$0.81
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The Hain Celestial Group is trading at a deep discount to its book and sales, with a price‑to‑book of 0.22 and price‑to‑sales of 0.05, while the forward P/E sits around 5.5. However, the company is reporting a steep negative profit margin of -36%, a ROE of -95%, and a debt‑to‑equity ratio exceeding 200%, indicating significant financial strain. Technically, the stock is above its 20‑day SMA but below the 50‑day and 200‑day averages, and the MACD histogram is only modestly bullish, suggesting limited upside momentum. Recent news shows a Barclays downgrade to Underweight and a 5.9% intraday drop, reinforcing short‑term bearish sentiment, even as analyst price targets imply up to 75% upside.
The market’s “Extreme Greed” sentiment contrasts sharply with the company’s high 30‑day volatility (>100%) and a historic max drawdown of nearly 85%. Given the increasing volume, the stock may find support near $0.58, but the current resistance around $0.87 looms. Investors must weigh the substantial valuation discount against the deteriorating earnings profile and heavy leverage when deciding on exposure.
The market’s “Extreme Greed” sentiment contrasts sharply with the company’s high 30‑day volatility (>100%) and a historic max drawdown of nearly 85%. Given the increasing volume, the stock may find support near $0.58, but the current resistance around $0.87 looms. Investors must weigh the substantial valuation discount against the deteriorating earnings profile and heavy leverage when deciding on exposure.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Barclays downgrade to Underweight
- Current price below 50‑day SMA indicating bearish trend
- High volatility and recent sharp price decline
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Significant valuation discount to book and sales
- Analyst price targets suggesting upside potential
- Continued earnings losses and high leverage
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Deep undervaluation relative to assets
- Long‑term growth of the natural and organic food market
- Potential for balance‑sheet restructuring and turnaround
Key Metrics & Analysis
Financial Health
Revenue Growth-6.70%
Profit Margin-36.12%
P/E Ratio5.5
ROE-95.83%
ROA1.65%
Debt/Equity232.07
P/B Ratio0.2
Op. Cash Flow$30.5M
Free Cash Flow$48.5M
Technical Analysis
TrendBearish
RSI57.1
Support$0.58
Resistance$0.87
MA 20$0.67
MA 50$0.85
MA 200$1.30
MACDBullish
VolumeIncreasing
Fear & Greed Index77.54
Valuation
Target Price$1.42
Upside/Downside75.41%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.10
Volatility101.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.